Skip to main content
. 2020 Feb 5;105(4):e1358–e1376. doi: 10.1210/clinem/dgaa049

Figure 1.

Figure 1.

Trial design. *Numbers in the treatment boxes show patients exposed to treatment. One patient in the somapacitan group did not receive any treatment and was not included in any analyses. The grey box indicates the main period of the trial. Purple bars indicate titration periods and green bars, fixed-dose treatment periods. Time axis is not to scale. Abbreviations: AGHD, adult growth hormone deficiency